Take a look at some of Friday’s morning movers:

Research In Motion - The BlackBerry maker reported adjusted quarterly earnings of 80 cents a share, a penny below estimates , with revenues also falling short. Former co-CEO Jim Balsillie has also resigned from the company’s board of directors. CEO Thorsten Heins says RIM is undertaking a major strategic revamping, and wouldn't rule out possible sale. A handful of analysts have slashed their price targets for RIM following the earnings report and the company’s statement that it would no longer issue financial forecasts.

Apple - The company and its supplier Foxconnagreed to fix violations of working conditions at Foxconn’s assembly plant in China.

GlaxoSmithKline - Its stock could be affected by results of a study involving Roche’s experimental breast cancer drug currently called T-DMI. Roche says the drug helped patients with an aggressive type of breast cancer live longer than those treated with a mix of Glaxo’s Tykerb and Roche’s Xeloda drugs.

Micron Technology, Oracle - The two have settled a lawsuit filed by Oracle over memory chip prices. The suit had accused Micron of starting a “conspiracy” to increase prices between 1998 and 2002. Terms of the settlement were not disclosed.

GSK News & Analysis

 UPDATE 3-Royalty raises Elan bid, issues ultimatum to shareholders - 20 hrs ago

 UPDATE 2-Royalty ups Elan bid and issues shareholder ultimatum - 22 hrs ago

 UPDATE 1-Elan strikes more deals to repel Royalty bid - 20 May 2013 EDT

 XenoPort: Horizant likely available in early June - 17 May 2013 EDT

 Espionage, comedy veterans touted for upcoming U.S. TV season - 16 May 2013 EDT

 More GSK News